Current location - Trademark Inquiry Complete Network - Tian Tian Fund - BD’s 100-year history of BD
BD’s 100-year history of BD

BD was founded in New York in 1897, and its former site is now preserved by the U.S. government as a cultural relic.

BD began producing glass and metal syringes and thermometers in 1898.

1924 BD begins producing insulin syringes.

In the 1940s, BD creatively invented the professional venous blood collection system and a series of other specimen collection products.

1961 BD invented the world's first disposable plastic syringe and disposable medical needle, leading the world into the stage of disposable medical products.

1966 BD was selected as one of the top 500 companies in the United States by Fortune magazine for the first time, and has been listed among the Fortune 500 many times since.

1973 BD launches the world's first commercial flow cytometer, establishing its leading position in the field of cytology research.

1975 BD produced the world's first BACTEC110 blood culture instrument.

1986 BD launched the first two-color fluorescent direct labeling reagent in the history of cell analysis.

1992 BD took the lead in launching self-destructing vaccine syringes and a new generation of safe injection disposable needles, and strongly supported the safe injection projects of UNICEF and the World Health Organization.

1995 BD produced the world's only fully automatic four-color flow cytometry sorter.

2003 BD launches a new BD patient identification system to reduce the potential for medical errors during sample collection.

2005 BD Diagnostics is able to enter the emerging industry of proteomics through technology and other assets from other companies' businesses.

2006 BD was included in the Medical and Health Equipment and Services Directory on the Forbes Platinum List of "America's Best Large Companies."

2007 BD launches the FACSCantoll system, which enables up to 8-color fluorescence analysis and stem cell SP detection. 2007 BD Diagnostics adds the TriPath series of products for rapid review and diagnosis of women’s cervical cancer. 2008 BD launches the upgraded flow cytometry sorter BD FACSAria II2005-2012 BD

Named one of the "Most Admired Companies" by Fortune magazine in the United States.

From 2007 to 2012, BD was continuously selected as one of the "World's Most Ethical Companies" by the American "Ethisphere" magazine.

2010-2012 BD was named one of the "Most Admired Companies" by Fortune magazine in the United States.